亚太药业
(002370)
| 流通市值：26.48亿 | | | 总市值：26.48亿 |
| 流通股本：7.40亿 | | | 总股本：7.40亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 689,103,730.3 | 686,352,627.85 | 663,138,268.39 | 720,474,524.86 |
| 应收票据及应收账款 | 80,215,026.89 | 74,656,806.86 | 72,355,842.66 | 79,510,294.14 |
| 应收账款 | 80,215,026.89 | 74,656,806.86 | 72,355,842.66 | 79,510,294.14 |
| 应收款项融资 | 19,738,669.93 | 26,326,103.71 | 39,106,611.62 | 32,288,532.83 |
| 预付款项 | 2,014,727.9 | 1,455,733.74 | 3,167,739.18 | 4,244,178.55 |
| 其他应收款合计 | 33,141,675.13 | 29,876,254.72 | 15,523,617.66 | 15,522,715.91 |
| 存货 | 69,366,932.16 | 81,522,997.59 | 91,613,598.11 | 89,474,526.05 |
| 其他流动资产 | 10,973,902.12 | 11,652,069.5 | 12,315,557.01 | 13,665,221.37 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 904,554,664.43 | 911,842,593.97 | 897,221,234.63 | 955,179,993.71 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 38,796,613.03 | 34,985,199.55 | 36,357,064.88 | 37,750,771.34 |
| 投资性房地产 | 619,657.62 | 628,419 | 637,180.38 | 645,941.76 |
| 固定资产 | 344,271,783.4 | 350,846,303.19 | 356,953,636.35 | 364,754,927.4 |
| 在建工程 | 979,260.02 | 798,888.34 | 781,944.84 | 33,628.32 |
| 无形资产 | 54,912,837.32 | 56,343,911.32 | 57,774,985.33 | 59,206,059.34 |
| 开发支出 | 13,637,951.45 | 12,996,442.01 | 12,557,762.76 | 11,133,234.46 |
| 长期待摊费用 | 251,100 | 301,320 | 351,540 | 232,518.69 |
| 其他非流动资产 | - | - | - | 436,332.8 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 453,469,202.84 | 456,900,483.41 | 465,414,114.54 | 474,193,414.11 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,358,023,867.27 | 1,368,743,077.38 | 1,362,635,349.17 | 1,429,373,407.82 |
| 流动负债: | | | | |
| 短期借款 | - | - | - | 50,059,583.33 |
| 应付票据及应付账款 | 34,906,289.49 | 44,182,363.87 | 51,418,088.71 | 51,796,562.84 |
| 其中：应付票据 | - | - | - | 2,320,000 |
| 应付账款 | 34,906,289.49 | 44,182,363.87 | 51,418,088.71 | 49,476,562.84 |
| 预收款项 | 6,880.78 | 27,522.97 | 48,165.16 | 68,807.35 |
| 合同负债 | 2,355,854.71 | 2,395,994.35 | 7,246,091.88 | 7,893,839.01 |
| 应付职工薪酬 | 8,528,257.23 | 8,487,351.57 | 8,218,460.39 | 11,728,418.48 |
| 应交税费 | 1,776,172.29 | 3,944,243.26 | 1,340,446.23 | 5,460,868.95 |
| 其他应付款合计 | 31,651,077.78 | 30,644,964.33 | 32,276,826.8 | 33,768,550.24 |
| 一年内到期的非流动负债 | 606,594,485.67 | 645,564,136.37 | - | 0 |
| 其他流动负债 | 306,261.11 | 311,479.27 | 941,991.94 | 1,026,199.07 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 686,125,279.06 | 735,558,055.99 | 101,490,071.11 | 161,802,829.27 |
| 非流动负债: | | | | |
| 应付债券 | - | - | 636,529,578.51 | 639,476,620.42 |
| 租赁负债 | - | - | - | 0 |
| 预计负债 | 38,043,600 | 38,043,600 | 38,043,600 | 38,043,600 |
| 递延收益 | 4,660,307.45 | 4,960,048.97 | 5,259,790.49 | 5,564,676.14 |
| 递延所得税负债 | 3,768,148.71 | 3,196,436.69 | 3,402,216.49 | 3,611,272.46 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 46,472,056.16 | 46,200,085.66 | 683,235,185.49 | 686,696,169.02 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 732,597,335.22 | 781,758,141.65 | 784,725,256.6 | 848,498,998.29 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 625,244,402 | 609,180,082 | 609,179,371 | 609,171,060 |
| 其他权益工具 | 129,159,197.14 | 139,388,669.86 | 139,389,306.64 | 139,396,735.7 |
| 资本公积 | 1,635,427,265.69 | 1,593,885,812.32 | 1,593,882,985.14 | 1,593,849,797.33 |
| 其他综合收益 | - | - | -598,381.19 | -598,381.19 |
| 盈余公积 | 60,559,514.31 | 60,559,514.31 | 60,559,514.31 | 60,559,514.31 |
| 未分配利润 | -1,824,963,847.09 | -1,816,029,142.76 | -1,824,502,703.33 | -1,821,504,316.62 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 625,426,532.05 | 586,984,935.73 | 577,910,092.57 | 580,874,409.53 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 625,426,532.05 | 586,984,935.73 | 577,910,092.57 | 580,874,409.53 |
| 负债和股东权益合计 | 1,358,023,867.27 | 1,368,743,077.38 | 1,362,635,349.17 | 1,429,373,407.82 |
| 公告日期 | 2024-10-31 | 2024-08-24 | 2024-04-27 | 2024-03-30 |
| 审计意见(境内) | | | | 标准无保留意见 |